Terms: = Sarcomas AND PPM1D, Wip1, 8493, ENSG00000170836, O15297, WIP1, PP2C-DELTA
12 results:
1. TRPM2-AS promotes the malignancy of osteosarcoma cells by targeting miR-15b-5p/ppm1d axis.
Cai Y; Yang Y; Zhang X; Ma Q; Li M
Cell Cycle; 2022 Apr; 21(8):835-850. PubMed ID: 35100080
[TBL] [Abstract] [Full Text] [Related]
2. A novel assay for screening wip1 phosphatase substrates in nuclear extracts.
Storchova R; Burdova K; Palek M; Medema RH; Macurek L
FEBS J; 2021 Oct; 288(20):6035-6051. PubMed ID: 33982878
[TBL] [Abstract] [Full Text] [Related]
3. ppm1d accelerates proliferation and metastasis of osteosarcoma by activating PKP2.
He XL; Xiao Q; Zhou ZP; Hui CY
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):78-85. PubMed ID: 33506895
[TBL] [Abstract] [Full Text] [Related]
4. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
Long X; Lin XJ
J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
[TBL] [Abstract] [Full Text] [Related]
5. Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in
Stolte B; Iniguez AB; Dharia NV; Robichaud AL; Conway AS; Morgan AM; Alexe G; Schauer NJ; Liu X; Bird GH; Tsherniak A; Vazquez F; Buhrlage SJ; Walensky LD; Stegmaier K
J Exp Med; 2018 Aug; 215(8):2137-2155. PubMed ID: 30045945
[TBL] [Abstract] [Full Text] [Related]
6. Novel regulatory role for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP in chemosensitization to bleomycin.
Masuda Y; Noguchi K; Segawa H; Tanaka N; Katayama K; Mitsuhashi J; Sugimoto Y
Biochem Biophys Res Commun; 2011 Nov; 415(2):305-12. PubMed ID: 22037577
[TBL] [Abstract] [Full Text] [Related]
7. Oncogenic wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.
Zhang X; Wan G; Mlotshwa S; Vance V; Berger FG; Chen H; Lu X
Cancer Res; 2010 Sep; 70(18):7176-86. PubMed ID: 20668064
[TBL] [Abstract] [Full Text] [Related]
8. Phosphorylation and degradation of MdmX is inhibited by wip1 phosphatase in the DNA damage response.
Zhang X; Lin L; Guo H; Yang J; Jones SN; Jochemsen A; Lu X
Cancer Res; 2009 Oct; 69(20):7960-8. PubMed ID: 19808970
[TBL] [Abstract] [Full Text] [Related]
9. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
[TBL] [Abstract] [Full Text] [Related]
10. The wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
[TBL] [Abstract] [Full Text] [Related]
11. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/wip1 pathway and silences p16 expression in human breast cancers.
Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J
Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432
[TBL] [Abstract] [Full Text] [Related]
12. A phage T7 class-III promoter functions as a polymerase II promoter in mammalian cells.
Sandig V; Lieber A; Bähring S; Strauss M
Gene; 1993 Sep; 131(2):255-9. PubMed ID: 8406019
[TBL] [Abstract] [Full Text] [Related]